Benjamin F. Edwards & Company’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$1K Sell
25
-427
-94% -$23.5K ﹤0.01% 2090
2024
Q1
$31K Buy
452
+179
+66% +$11.3K ﹤0.01% 1421
2023
Q4
$20K Buy
273
+248
+992% +$16.3K ﹤0.01% 1487
2023
Q3
$2K Hold
25
﹤0.01% 1667
2023
Q2
$2K Hold
25
﹤0.01% 1665
2023
Q1
$2K Hold
25
﹤0.01% 1673
2022
Q4
$1K Hold
25
﹤0.01% 1778
2022
Q3
$1K Sell
25
-20
-44% -$825 ﹤0.01% 1755
2022
Q2
$2K Hold
45
﹤0.01% 1682
2022
Q1
$3K Sell
45
-20
-31% -$1.46K ﹤0.01% 1606
2021
Q4
$5K Hold
65
﹤0.01% 1523
2021
Q3
$6K Hold
65
﹤0.01% 1485
2021
Q2
$8K Hold
65
﹤0.01% 1418
2021
Q1
$9K Buy
+65
New +$8.9K ﹤0.01% 1383
2020
Q2
Sell
-470
Closed -$27K 1700
2020
Q1
$27K Buy
+470
New +$38.2K ﹤0.01% 986
2019
Q3
Sell
-27
Closed -$3K 1872
2019
Q2
$3K Buy
+27
New +$2.72K ﹤0.01% 1728
2018
Q4
Sell
-31
Closed -$2K 1708
2018
Q3
$2K Hold
31
﹤0.01% 1518
2018
Q2
$2K Buy
31
+11
+55% +$592 ﹤0.01% 1516
2018
Q1
$1K Buy
+20
New +$976 ﹤0.01% 1560
2016
Q2
Sell
-370
Closed -$2K 1098
2016
Q1
$2K Hold
370
﹤0.01% 1018
2015
Q4
$3K Sell
370
-100
-21% -$930 ﹤0.01% 1030
2015
Q3
$8K Buy
470
+100
+27% +$2.3K ﹤0.01% 914
2015
Q2
$11K Buy
+370
New +$9.29K ﹤0.01% 909

Other funds holding EXAS

Benjamin F. Edwards & Company's EXAS Position: Q2 2024 in Review

Benjamin F. Edwards & Company reduced its Exact Sciences (EXAS) stake by 94% in Q2 2024, selling an estimated $23.5K and leaving 25 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2090.

Benjamin F. Edwards & Company first reported a position in EXAS in Q2 2015 and has held it in 23 quarters since. The position peaked at $31K in Q1 2024. 544 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Benjamin F. Edwards & Company held 25 shares of Exact Sciences worth $1K as of Q2 2024.
  • Benjamin F. Edwards & Company sold 427 Exact Sciences shares in Q2 2024, an estimated $23.5K.
  • Exact Sciences made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #2090 holding.
  • Benjamin F. Edwards & Company first reported a position in Exact Sciences in Q2 2015 and has held it in 23 quarters since.
  • Benjamin F. Edwards & Company's Exact Sciences position peaked at $31K in Q1 2024.
  • 544 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.